Patents by Inventor Jean-Marie Pleau

Jean-Marie Pleau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7309690
    Abstract: The present invention relates to the utilization of peptide analogues of thymulin that are inactive relative to the immune system, not comprising zinc and having anti-pain activity, for manufacturing a medicine for the treatment of pain.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: December 18, 2007
    Assignees: Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Mireille Dardenne, Jean-François Bach, Bared Safieh-Garabedian, Jean-Marie Pleau, Nayef Saade
  • Publication number: 20050261194
    Abstract: The present invention relates to the utilization of peptide analogues of thymulin that are inactive relative to the immune system, not comprising zinc and having anti-pain activity, for manufacturing a medicine for the treatment of pain.
    Type: Application
    Filed: October 8, 2002
    Publication date: November 24, 2005
    Inventors: Mireille Dardenne, Jean-Francois Bach, Bared Safieh-Garabedian, Jean-Marie Pleau, Nayef Saade
  • Patent number: 4680276
    Abstract: The present invention relates to novel peptide compounds, of which the chemical structure is related to that of the polypeptide hormone having a thymic activity, isolated from the blood serum of pig, and the application of these novel compounds for therapeutic purposes. This invention also relates to intermediates useful in preparing the active compounds of the invention.
    Type: Grant
    Filed: September 10, 1984
    Date of Patent: July 14, 1987
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Jean-Francois Bach, Mireille Dardenne, Jean-Marie Pleau, Jean Hamburger, Evangheios Bricas, Jean Martinez, Didier Blanot, Genevieve Auger, Pierre Lefrancier, Bernard Amor
  • Patent number: 4301065
    Abstract: The invention is concerned with novel polypeptides and processes for the synthesis thereof.It is concerned with compounds having the sequenceX-Gln-Gly-Gly-Yin which Y represents -Ser-Asn and X represents Ser-, Lys-Ser-, Ala-Lys-Ser-, Glx-Ala-Lys-Ser-; Glx representing Pyro-Glu or Gln; and when X represents Glx-Ala-Lys-Ser-, Y may in addition represent -Ser; as well as their derivatives comprising one or two modified amino acids, with the exception of the unmodified compound PyroGlu-Ala-Lys-Ser-Gln-Gly-Ser-Asn.These polypeptides are useful as medicines.
    Type: Grant
    Filed: May 24, 1978
    Date of Patent: November 17, 1981
    Assignee: Agence Nationale de Valorisation de la Recherche (ANVAR)
    Inventors: Jean-Francois Bach, Mireille Dardenne, Jean-Marie Pleau, Jean Hamburger, Evanghelos Bricas, Jean Martinez, Didier Blanot, Genevieve Auger